Get breaking news alerts via email

Click here to manage your alerts
Salt Lake City-based Q Therapeutics gets FDA help for treatment of Lou Gehrig’s disease
Medical » Company will get additional funding and tax credits to help further develop treatment.
First Published Nov 19 2013 03:53 pm • Last Updated Nov 19 2013 03:53 pm

Salt Lake City-based Q Therapeutics, which develops adult stem cell therapies for diseases such as multiple sclerosis and Lou Gehrig’s disease, was granted a drug designaton for its Q-Cells product that gives the company additional funding, tax credits and exclusivity to sell the product.

The company announced Tuesday that Q-Cells was given a Company Orphan Drug Designation from the Federal Drug Administration, which allows Q Therapeutics to market the product exclusively for seven years. The drug is used to treat Amyotrophic Lateral Sclerosis (ALS), also known as Lou Gehrig’s disease. The designation also will help defray clinical trial costs and provides assistance with clinical protocols, according to a company statement.

Join the Discussion
Post a Comment

"Designation of Q-Cells as an orphan drug for the treatment of ALS is a significant milestone for ALS patients, who have few treatment options, and for our company as we advance this potentially life-saving therapeutic," Dr. Deborah Eppstein, president and CEO of Q Therapeutics, said in the statement.

Copyright 2014 The Salt Lake Tribune. All rights reserved. This material may not be published, broadcast, rewritten or redistributed.

Top Reader Comments Read All Comments Post a Comment
Click here to read all comments   Click here to post a comment

About Reader Comments

Reader comments on sltrib.com are the opinions of the writer, not The Salt Lake Tribune. We will delete comments containing obscenities, personal attacks and inappropriate or offensive remarks. Flagrant or repeat violators will be banned. If you see an objectionable comment, please alert us by clicking the arrow on the upper right side of the comment and selecting "Flag comment as inappropriate". If you've recently registered with Disqus or aren't seeing your comments immediately, you may need to verify your email address. To do so, visit disqus.com/account.
See more about comments here.
Staying Connected
Contests and Promotions
  • Search Obituaries
  • Place an Obituary

  • Search Cars
  • Search Homes
  • Search Jobs
  • Search Marketplace
  • Search Legal Notices

  • Other Services
  • Advertise With Us
  • Subscribe to the Newspaper
  • Access your e-Edition
  • Frequently Asked Questions
  • Contact a newsroom staff member
  • Access the Trib Archives
  • Privacy Policy
  • Missing your paper? Need to place your paper on vacation hold? For this and any other subscription related needs, click here or call 801.204.6100.